Clinical Trial Update: Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing 17β-estradiol/TMG CC 1 mg with tibolone in postmenopausal women with vasomotor symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• 17β-estradiol/TMG CC 1 mg (17β-estradiol; TMG CC)
• Tibolone (tibolone)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Vasomotor Symptoms | Phase 4 | Status: COMPLETED